ESR1 and breast cancer: To further interpret the mechanisms of epigenetic modulations on EGCG-induced ERα re-expression in ERα-negative breast cancer cells, we assessed the histone acetylation-related enzymatic activities including the activities of histone acetyltransferases (HATs) and deacetylases (HDACs).